GHESKIO Institute of Infectious Diseases and Reproductive Health (GHESKIO – IMIS) CRS

Location	Chateaublond Tabarre 41 Port Au Prince, Haiti
CRS Coordinator	Sandy Nerette snerette@gheskio.org 509-31708270
CRS Leader	Damocles Patrice Severe patsevere@gheskio.org 509-29401431
Studies	A5243: Non-US Genomic Sampling A5300B:Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Participants (PHOENIx) A5381: Observational Cohort to Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of Tenofovir-Lamivudine-Dolutegravir (TLD) for First- or Second-Line ART A5332: REPRIEVE Trial A5372: Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals (RPT-DTG PK Study) A5379: B-Enhancement of HBV vaccination in persons living with HIV (BEe-HIVe): Evaluation of HEPLISAV-B